Podoplanin expression in oral leukoplakia: Tumorigenic role

Oral Oncology

Volumn 49, Issue 6, 2013, Pages 598-603

  De Vicente, Juan Carlos ^a,b   Rodrigo, Juan Pablo ^a,b   Rodriguez Santamarta, Tania ^a   Lequerica Fernández, Paloma ^b   Allonca, Eva ^b   García Pedrero, Juana María ^b  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

Epithelial dysplasia; Immunohistochemistry; Malignant transformation; Oral cancer; Oral leukoplakia; Podoplanin; Squamous cell carcinoma

Indexed keywords

PODOPLANIN;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MOUTH CANCER; MOUTH MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOGENESIS; FEMALE; HUMANS; LEUKOPLAKIA, ORAL; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MOUTH NEOPLASMS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84877062618     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.02.008     Document Type: Article

References (26)

1. N.W. Johnson, P. Jayasekara, and A.A. Amarasinghe Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology Periodontol 2000 57 1 2011 19 37
2. S. Warnakulasuriya, N.W. Johnson, and I. van der Waal Nomenclature and classification of potentially malignant disorders of the oral mucosa J Oral Pathol Med 36 10 2007 575 580
3. V.A. Papadimitrakopoulou, W.K. Hong, J.S. Lee, J.W. Martin, J.J. Lee, and J.G. Batsakis Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up J Natl Cancer Inst 89 3 1997 257 258
4. S. Silverman Jr., M. Gorsky, and F. Lozada Oral leukoplakia and malignant transformation. A follow-up study of 257 patients Cancer 53 3 1984 563 568
5. J.J. Lee, W.K. Hong, W.N. Hittelman, L. Mao, R. Lotan, and D.M. Shin Predicting cancer development in oral leukoplakia: ten years of translational research Clin Cancer Res 6 5 2000 1702 1710
6. L.M. Abbey, G.E. Kaugars, J.C. Gunsolley, J.C. Burns, D.G. Page, and J.A. Svirsky Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia Oral Surg Oral Med Oral Pathol Oral Radiol Med 80 2 1995 188 191
7. H. Kawaguchi, A.K. El-Naggar, V. Papadimitrakopoulou, H. Ren, Y.H. Fan, and L. Feng Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy J Clin Oncol 26 3 2008 354 360
8. J.P. Rodrigo, D. García-Carracedo, M.V. González, G. Mancebo, M.F. Fresno, and J. García-Pedrero Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas Mol Cancer 9 2010 48
9. H.J. Kahn, and A. Marks A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors Lab Invest 82 9 2002 1255 1257
10. A. Wicki, and G. Christofori The potential role of podoplanin in tumour invasion Br J Cancer 96 1 2007 1 5
11. E. Martín-Villar, F.G. Scholl, C. Gamallo, M.M. Yurrita, M. Muñoz-Guerra, and J. Cruces Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas Int J Cancer 113 6 2005 899 910
12. S.K. Mithani, W.K. Mydlarz, F.L. Grumbione, I.M. Smith, and J.A. Califano Molecular genetics of premalignant oral lesions Oral Diseases 13 2 2007 126 133
13. World Health Organization Classification of Tumours. Pathology & Genetics of Head and Neck Tumours. International Agency for Research on Cancer (IARC). In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. Head and neck tumors. Lyon: IARC Press, 2005. p. 177-80.
14. P. Yuan, S. Temam, A. El-Naggar, X. Zhou, D.D. Liu, and J.J. Lee Overexpression of podoplanin in oral cancer and its association with poor clinical outcome Cancer 107 3 2006 563 569
15. M. Kreppel, B. Kreppel, U. Drebber, I. Wedemayer, D. Rothamel, and J.E. Zöller Podoplanin expression in oral leukoplakia: prognostic value and clinicopathological implications Oral Dis 18 7 2012 692 699
16. A.W. Hamburger, and S.E. Salmon Primary bioassay of human tumor stem cells Science 197 4302 1977 461 463
17. M. Al-Hajj, and M.F. Clarke Self-renewal and solid tumor stem cells Oncogene 23 43 2004 7274 7282
18. N. Atsumi, G. Ishii, M. Kojima, M. Sanada, S. Fujii, and A. Ochiai Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431 Biochem Biophys Res Commun 373 1 2008 36 41
19. A. Kunita, T.G. Kashima, Y. Morishita, M. Fukayama, Y. Kato, and T. Tsuruo The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis Am J Pathol 170 4 2007 1337 1347
20. E. Martín-Villar, D. Megías, S. Castel, M.M. Yurrita, S. Vilaró, and M. Quintanilla Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition J Cell Sci 119 Pt 21 2006 4541 4553
21. A. Wicki, F. Lehembre, N. Wick, B. Hantusch, D. Kerjaschki, and G. Christofori Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton Cancer Cell 9 4 2006 261 272
22. M. Kreppel, M. Scheer, U. Drebber, L. Ritter, and J.E. Zöller Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations Virchows Arch 456 5 2010 473 482
23. L. Vormittag, D. Thurnher, S. Geleff, J. Pammer, G. Heiduschka, and M. Brunner Co-expression of Bmi-1 and podoplanin predicts overall survival in patients with squamous cell carcinoma of the head and neck treated with radio(chemo)therapy Int J Radiat Oncol Biol Phys 73 3 2009 913 918
24. P. Shi, W. Liu, Z.T. Zhou, Q.B. He, and W.W. Jiang Podoplanin and ABCG2: malignant transformation risk markers for oral lichen planus Cancer Epidemiol Biomarkers Prev 19 3 2010 844 849
25. P. Holmstrup, P. Vedtofte, J. Reibel, and K. Stoltze Oral premalignant lesions: is a biopsy reliable? J Oral Pathol Med 36 5 2007 262 266
26. P. Holmstrup, P. Vedtofte, J. Reibel, and K. Stoltze Long-term treatment outcome of oral premalignant lesions Oral Oncol 42 5 2006 461 474